A diverse network of regulatory mechanisms—including RNA modifications, viral proteins, methylation events, microenvironmental signals, and immune-evasive transcriptional feedback—converge on the Nrf2–SLC7A11–GPX4 axis to protect tumor cells. The gene discussed is NFE2L2; the disease is neoplasm.